Vir Biotechnology (VIR) Stock Price, Quote, News & History

Comments

Vir Biotechnology Inc (VIR) Stock Price, Quote, News & History

VIRNASDAQ

Trade with Public

$9.09

-0.23-2.47%

At close: Feb 27, 4:00 PM EST

$9.09

-0.0035-0.04%

After Hours: Feb 27, 7:59 PM EST

Earnings: Q4 2025 Earnings were released on Mon Feb 23rd, after the market close

Conference Call: The most recent conference call started at 5:30 PM, 6 days ago

Click to view the webcast

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$9.29

Close

$9.09

Volume / Avg.

5.40M / 3.03M

Day Range

$8.89 - $9.50

52 Wk Range

4.16 - 10.94

Market Cap

$1.26B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

14.94%

Days to Cover

8.75

Recent Vir Biotechnology Inc News

C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

These Analysts Boost Their Forecasts On Vir Biotechnology

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-453.54M

Investing Cash Flow (TTM)

364.46M

Financing Cash Flow (TTM)

4.01M

Free Cash Flow (TTM)

-460.02M

Capital Expenditure (TTM)

-6.48M

Net Change in Cash (TTM)

-85.07M

Analyst Trends and Forecast

2

Sep 25

1

Dec 25

5

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$859.70M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

91.47

PB Ratio (TTM)

1.63

Earnings Yield % (TTM)

-38.88%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.72

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$170.08M

Debt to Equity

0.13

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$9.29

Close

$9.09

Volume / Avg.

5.40M / 3.03M

Day Range

$8.89 - $9.50

52 Wk Range

4.16 - 10.94

Market Cap

$1.26B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

14.94%

Days to Cover

8.75

About

Sector

Health Care

Industry

Biotechnology

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Vir Biotechnology (VIR) stock?

A

You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vir Biotechnology (VIR) competitors?

A

Other companies in Vir Biotechnology’s space includes: Precigen Inc (NASDAQ:PGEN), MoonLake Immunotherapeutics (NASDAQ:MLTX), Immatics NV (NASDAQ:IMTX), Day One Biopharmaceuticals Inc (NASDAQ:DAWN) and Pharming Group (NASDAQ:PHAR).

Q

What is the forecast, or price target, for Vir Biotechnology (VIR) stock?

A

Vir Biotechnology has a consensus price target of $27.25.

Q

What is the current price for Vir Biotechnology (VIR)?

A

The stock price for Vir Biotechnology (NASDAQ: VIR) is $9.0865 last updated February 27, 2026 at 7:59 PM EST.

Q

Does Vir Biotechnology (VIR) pay a dividend?

A

There are no upcoming dividends for Vir Biotechnology.

Q

When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?

A

Vir Biotechnology does not have any upcoming earnings scheduled.

Q

Is Vir Biotechnology (VIR) going to split?

A

There is no upcoming split for Vir Biotechnology.

Q

What sector and industry does Vir Biotechnology (VIR) operate in?

A

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

MoonLake Immunotherapeutics

Day One Biopharmaceuticals Inc

Monte Rosa Therapeutics Inc

NASDAQ:GLUE

$17.90

0.85%

ORIC Pharmaceuticals Inc

NASDAQ:ORIC

$13.45

%

Key Statistics

Open

$9.29

Close

$9.09

Volume / Avg.

5.40M / 3.03M

Day Range

$8.89 - $9.50

52 Wk Range

4.16 - 10.94

Market Cap

$1.26B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

14.94%

Days to Cover

8.75

Recent Vir Biotechnology Inc News

C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

These Analysts Boost Their Forecasts On Vir Biotechnology

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-453.54M

Investing Cash Flow (TTM)

364.46M

Financing Cash Flow (TTM)

4.01M

Free Cash Flow (TTM)

-460.02M

Capital Expenditure (TTM)

-6.48M

Net Change in Cash (TTM)

-85.07M

Analyst Trends and Forecast

2

Sep 25

1

Dec 25

5

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$859.70M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

91.47

PB Ratio (TTM)

1.63

Earnings Yield % (TTM)

-38.88%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.72

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$170.08M

Debt to Equity

0.13

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$9.29

Close

$9.09

Volume / Avg.

5.40M / 3.03M

Day Range

$8.89 - $9.50

52 Wk Range

4.16 - 10.94

Market Cap

$1.26B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

14.94%

Days to Cover

8.75

About

Sector

Health Care

Industry

Biotechnology

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry